Aktienanalyse zu SelectQuote Inc (SLQT)SLQTSelectQuote Inc

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy. It operates in the Financials sector (INSURANCE AGENTS, BROKERS & SERVICE industry).

SelectQuote Inc (SLQT) is not a good buy right now due to significant recent losses and declining revenue. The current price is $0.52, which is a staggering 75.93% lower than one year ago. Additionally, the stock has a very low RSI of 18.14, indicating it is oversold, but this also suggests a lack of buying momentum. The forward P/E ratio is extremely high at 66.67, which reflects overvaluation concerns given the company's recent performance. The main risk is the reported revenue decline of 6.7% in Q4 FY2026, which could further impact investor confidence and stock performance.